REGENERON PHARMACEUTICALS, INC. (REGN) Net income 2016–2025
REGENERON PHARMACEUTICALS, INC. (REGN) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$4.5BFY2025 · since FY2016: $895.5M → $4.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.5B | +2.1% |
| FY2024 | $4.4B | +11.6% |
| FY2023 | $4.0B | -8.9% |
| FY2022 | $4.3B | -46.3% |
| FY2021 | $8.1B | +129.9% |
| FY2020 | $3.5B | +66.0% |
| FY2019 | $2.1B | -13.4% |
| FY2018 | $2.4B | +104.0% |
| FY2017 | $1.2B | +33.8% |
| FY2016 | $895.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice